Adults including elderly: One 1 mg tablet to be taken orally once a day. For patients with advanced breast cancer, ARIMIDEX should be continued until tumour progression.
Children: The use of ARIMIDEX is not recommended in children, as efficacy has not been established.
Renal impairment: No dose change is recommended in patients with mild or moderate renal impairment.
Hepatic impairment: No dose change is recommended in patients with mild hepatic disease.